HBIO 2.16 (+5.37%)
US4169061052• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. HBIO

Harvard Bioscience (HBIO) Competitor Comparison

We are evaluating the key criteria listed to compare Harvard Bioscience (HBIO) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

34 / 44

Gross Profits

29 / 40

Total Revenue

31 / 43

EBITDA

25 / 44

Free Cashflow

26 / 44

Quick Ratio

41 / 44

Earnings per Share

24 / 44

Dividend yield

0 / 13

Total Cash

40 / 44

Performance 3 years

34 / 44

Performance 5 years

20 / 44

Performance 10 years

32 / 44

Linearity 3 years

28 / 44

Linearity 5 years

9 / 44

Linearity 10 years

11 / 44

Total Rank

36 / 44

Dividend Rank

42 / 44

Valuation Rank

30 / 44

Piotroski Rank

38 / 44

Muliplier Rank

41 / 44

EBITDA - HBIO ranking 25 / 44

These are the competitors of Harvard Bioscience in the industry Medical Instruments & Supplies ranked by ebitda
1. Becton, Dickinson BDX
5.04B
2. Baxter BAX
3.06B
3. Intuitive Surgical ISRG
2.11B
4. Alcon ALC
2.11B
5. Steris STE
1.39B
6. ResMed RMD
1.31B
7. Hologic HOLX
1.28B
8. West Pharmaceutical Services WST
880.6M
9. Cooper Companies COO
872.2M
10. Teleflex TFX
807.9M
11. Dentsply Sirona XRAY
627M
12. Bausch & Lomb BLCO
556M
13. Envista Holdings NVST
502.7M
14. Masimo MASI
302.3M
15. ICU Medical ICUI
290.27M
16. Haemonetics HAE
288.62M
17. Ansell PD1.F
254.2M
18. Merit Medical Systems MMSI
213.05M
19. Repligen RGEN
144.13M
20. OraSure Technologies OSUR
71.15M
21. LeMaitre Vascular LMAT
43.32M
22. Atrion ATRI
39.28M
23. Utah Medical Products UTMD
25.6M
24. Staar Surgical STAA
24.19M
25. Harvard Bioscience HBIO
10.31M
26. Pro-Dex PDEX
7.59M
27. AngioDynamics ANGO
4.57M
28. Nephros NEPH
-1.42M
29. NexGel NXGL
-2.76M
30. NeuroMetrix NURO
-6.11M
31. AtriCure ATRC
-8.6M
32. KORU Medical Systems KRMD
-8.95M
33. Microbot Medical MBOT
-10.75M
34. Femasys FEMY
-12.53M
35. Predictive Oncology POAI
-13.93M
36. Ekso Bionics Holdings EKSO
-14.82M
37. electroCore ECOR
-19.66M
38. Warby Parker WRBY
-35.04M
39. Pulse Biosciences PLSE
-38.55M
40. BioLife Solutions BLFS
-40.82M
41. Akoya Biosciences AKYA
-55.62M
42. iRhythm Technologies IRTC
-81.82M
43. Glaukos GKOS
-87.49M
44. NovoCure NVCR
-213.63M
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.